MD Anderson advances data collaboration through technology agreement with Syntropy
The University of Texas MD Anderson Cancer Center today announced efforts to advance its capabilities to seamlessly connect basic science, translational and clinical research data for the benefit of patients through a technology collaboration with Syntropy and the Foundry platform. This initiative is part of MD Anderson’s new Strategy aimed at focusing its mission to end cancer on approaches that maximize the impact on humanity, which...
MD Anderson researcher Sharon Dent elected to American Academy of Arts and Sciences
Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis, and director of the Virginia Harris Cockrell Cancer Research Center...
Genetic diversity within tumors suggests continuous evolution
By analyzing tumors from more than 2,600 patients and from 38 cancer types, researchers from The University of Texas MD Anderson Cancer Center...